Document is current

Article History

Accepted: 18 July 2023

First Online: 12 August 2023

Declarations

:

: This article does not contain any studies with human or animal subjects performed by any of the authors.

: AG and LV declare no competing interests. Mark J. Burish (MJB) was an unpaid medical advisor for Praxis Precision Medicines (in lieu of compensation a fee was paid to the University of Texas Health Science Center at Houston) and was an unpaid consultant for Beckley Psytech limited (in lieu of compensation a donation was made to the Will Erwin Headache Research Foundation). It should be noted, however, that Dr. Burish is employed by the University of Texas Health Science Center at Houston and receives research funding from the Will Erwin Headache Research Foundation. He is an unpaid member of the medical advisory board of Clusterbusters and is a site investigator for a cluster headache clinical trial funded by Lundbeck. He was paid to take surveys for Doximity. Dr. Szperka (CLS) or her institution have received compensation for serving as a consultant for Teva, Lundbeck, AbbVie, and Impel. She has received personal compensation for serving on a scientific advisory or data safety monitoring board for Eli Lilly and Upsher-Smith. She has also received research support from the PCORI, and the NIH NINDS (K23NS102521). Dr. Szperka has received compensation for serving as an editor from Elsevier.